Genfosis Update
News & Articles
China’s Breakthrough in Diabetes Treatment: Stem Cell Therapy for a Future Without Insulin
Chinese scientists have developed a pioneering stem cell therapy that could transform diabetes care worldwide. Early trials show that patients with both Type 1 and Type 2 diabetes became insulin-free within weeks. This breakthrough not only brings new hope to over 500 million patients but also poses significant challenges to the global healthcare system and pharmaceutical industry.
Revolutionary Down Syndrome Treatment: CRISPR-Cas9 Successfully Eliminates Extra Chromosomes
A groundbreaking technique from Japan may redefine the future of Down syndrome treatment. CRISPR-Cas9 has been used to successfully eliminate the extra chromosome in human cells. What was once impossible may now be within reach.
Longevity Technology 2026 | 5 Emerging Health Tech Trends for Clinics
Explore 5 top longevity tech trends of 2026 — biological age testing, AI health coaching, multi-omics personalization
Wellness & Longevity Program for Executives (WLE3)
Genfosis CEO Lectures on Precision Medicine at Executive Wellness Program
Genfosis's 'Longevity in Action' Event
Genfosis's 'Longevity in Action' Event Draws Top Public and Private Sector Leaders
DST Annual Meeting 2025
Genfosis Showcases Genetic and Epigenetic Technology at DST Annual Meeting 2025
Special Event - Longevity in Action by Genfosis
Genfosis Gathers Industry Leaders for "Longevity in Action" Event
TED Fund Grant Day 2024
Genfosis Awarded Grant from TED Fund, Participates in Grant Day 2024
Lessons Learned from Deep Tech CEOs" Seminar
Genfosis CSO Shares Insights at "Lessons Learned from Deep Tech CEOs" Seminar